\"HHS can clearly insist on limiting the U.S. price of Xtandi to the median price for other large high-income countries,\" said advocates, \"particularly since the drug has already generated more than $10 billion in sales from Medicare alone based upon these unconscionable pricing disparities.\"... Welcome to the United States of Greed!